ArriVent BioPharma Inc.
AVBP | NASDAQ
$30.09
+$0.35 (+1.18%)
Sep 22, 2026, 10:32 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -163.74M | -145.24M | -166.31M | -151.4M | -136.98M | -127.46M | -80.49M | -81.05M | -74.89M | -74.58M | -69.33M | -58.58M | -55.95M | -34.38M | -22.21M | -11.77M | -14.7M | -7.35M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 19.09M | 15.73M | 12.52M | 10.25M | 7.4M | 4.85M | 3.21M | 2.58M | 1.93M | 1.35M | 895K | 689K | 585K | 392K | 226K | 113K | 198K | 99K |
Other Working Capital | 10.07M | -5.75M | -5.92M | -6.22M | 2.71M | 2.81M | 7.82M | 9.09M | 7.54M | 14.25M | 11.22M | -26K | -1.46M | -10.54M | -6.04M | -466K | -3.91M | -1.95M |
Other Non-Cash Items | -11.5M | -3.59M | -3.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 586K | 293K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 8.22M | -1.38M | -3.77M | -4.94M | 2.95M | 3.01M | 7.07M | 9.5M | 4.89M | 15.64M | 12.6M | 1.08M | 4.06M | -8.7M | -3.83M | 1.73M | -3.91M | -1.95M |
Operating Cash Flow | -147.93M | -134.47M | -160.59M | -146.08M | -126.63M | -119.59M | -70.21M | -68.97M | -68.07M | -57.59M | -55.84M | -56.82M | -51.3M | -42.69M | -25.81M | -9.93M | -17.82M | -8.91M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -319.92M | -327.5M | -272.93M | -315.92M | -225.55M | -203.98M | -194.16M | n/a | n/a | -25M | -25M | -25M | -25M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 247.62M | 223.03M | 201.71M | 121.73M | 82.12M | 46.64M | n/a | 25M | 25M | 25M | 25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 1.7M | 1.7M | 1.7M | 1.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -72.31M | -104.47M | -71.23M | -192.49M | -141.73M | -155.64M | -192.47M | 25M | 25M | n/a | n/a | -25M | -25M | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -70K | -297K | -297K | -227K | -227K | 44K | 45K | 45K | -988K | -1.03M | -1.01M | -992K | 41K | 41K | 15K | n/a | 60M | 30M |
Financial Cash Flow | 262.15M | 251.18M | 203.06M | 168.39M | 82.46M | 7.71M | 186.58M | 185.47M | 183.91M | 183.52M | 42.86M | 153.64M | 154.67M | 154.69M | 109.72M | n/a | 60M | 30M |
Net Cash Flow | 41.92M | 12.24M | -28.75M | -170.18M | -185.9M | -267.53M | -76.1M | 141.5M | 140.84M | 125.93M | -12.98M | 71.82M | 78.37M | 112M | 83.91M | -9.93M | 79.46M | n/a |
Free Cash Flow | -147.93M | -134.47M | -160.59M | -146.08M | -126.63M | -119.59M | -70.21M | -68.97M | -68.07M | -57.59M | -55.84M | -56.82M | -51.3M | -42.69M | -25.81M | -9.93M | -17.82M | -8.91M |
Adj. Free Cash Flow | -167.02M | -150.21M | -173.11M | -156.33M | -134.03M | -124.45M | -73.42M | -71.55M | -70M | -58.94M | -56.74M | -57.51M | -51.89M | -43.09M | -26.04M | -10.04M | -18.02M | -9.01M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -147.93M | -134.47M | -160.59M | -146.08M | -126.63M | -119.59M | -70.21M | -68.97M | -68.07M | -57.59M | -55.84M | -56.82M | -51.3M | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove AVBP